Literature DB >> 3488139

von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries.

T C Nichols, D A Bellinger, T A Johnson, M A Lamb, T R Griggs.   

Abstract

We studied the role of von Willebrand factor in coronary thrombosis in normal, heterozygous, and homozygous von Willebrand's disease pigs by producing coronary stenosis with a Goldblatt clamp positioned around the left anterior descending coronary artery. Flow velocity was assessed by a 20-MHz Doppler velocity probe distal to the Goldblatt clamp. Myocardial extracellular potassium levels were measured by potassium-sensitive electrodes in myocardium supplied by the left anterior descending artery. Whereas stenosis sufficient to block reactive hyperemia to a 20-second occlusion produced an elevation of myocardial extracellular potassium, it produced neither spontaneous cyclic flow reductions nor permanent cessation of coronary blood flow velocity. Injury of the coronary artery at the stenosis site with spring-loaded forceps produced cyclic flow reductions or permanent cessation of flow in eight of nine phenotypically normal pigs. On the other hand, flow variations occurred in none of the 10 von Willebrand's disease pigs, including four given purified von Willebrand factor at a dose that failed to correct the bleeding time (p less than 0.001, chi 2 test). Permanent cessation of flow was caused by an occlusive platelet-fibrin-red-blood-cell thrombus. Scanning electron micrographs from pigs with cyclic flow variations and from von Willebrand's disease pigs showed injured endothelium covered by adherent platelets, red and white blood cells, and fibrin. These data suggest an important role of native von Willebrand factor in sudden occlusive arterial thrombosis following stenosis and intimal injury.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488139     DOI: 10.1161/01.res.59.1.15

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  12 in total

Review 1.  The hemostatic balance revisited through the lessons of mankind evolution.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Intern Emerg Med       Date:  2008-02-19       Impact factor: 3.397

Review 2.  von Willebrand factor.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

3.  Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras.

Authors:  T C Nichols; C M Samama; D A Bellinger; J Roussi; R L Reddick; M Bonneau; M S Read; O Bailliart; G G Koch; M Vaiman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

4.  Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery.

Authors:  M Prosdocimi; A Zatta; M Finesso
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

5.  A comparative study of the antithrombotic effect of aurintricarboxylic acid on arterial thrombosis in rats and guinea pigs.

Authors:  Y Takiguchi; M Shimazawa; M Nakashima
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Porcine von Willebrand disease and atherosclerosis. Influence of polymorphism in apolipoprotein B100 genotype.

Authors:  T C Nichols; D A Bellinger; K E Davis; G G Koch; R L Reddick; M S Read; J Rapacz; J Hasler-Rapacz; K M Brinkhous; T R Griggs
Journal:  Am J Pathol       Date:  1992-02       Impact factor: 4.307

7.  Preservation of hemostatic and structural properties of rehydrated lyophilized platelets: potential for long-term storage of dried platelets for transfusion.

Authors:  M S Read; R L Reddick; A P Bode; D A Bellinger; T C Nichols; K Taylor; S V Smith; D K McMahon; T R Griggs; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-17       Impact factor: 11.205

8.  A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected].

Authors:  H R Gralnick; S Williams; L McKeown; W Kramer; H Krutzsch; M Gorecki; A Pinet; L I Garfinkel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

9.  Prevention of occlusive coronary artery thrombosis by a murine monoclonal antibody to porcine von Willebrand factor.

Authors:  D A Bellinger; T C Nichols; M S Read; R L Reddick; M A Lamb; K M Brinkhous; B L Evatt; T R Griggs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

10.  Determinants of disease and disability in the elderly: the Rotterdam Elderly Study.

Authors:  A Hofman; D E Grobbee; P T de Jong; F A van den Ouweland
Journal:  Eur J Epidemiol       Date:  1991-07       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.